FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to novel compounds of general formula (I), as well as to pharmaceutical compositions based thereon, to drugs having inhibitory action on URAT1.
EFFECT: obtaining novel compounds having inhibitory action on URAT1, which can be used in treating mediated diseases, such as gout or hyperuricemia.
44 cl, 3 tbl, 119 ex
Title | Year | Author | Number |
---|---|---|---|
QUINOLINE DERIVATIVES | 1995 |
|
RU2137770C1 |
REGULATORS OF DERIVATIVES OF STEROIDS, METHODS OF THEIR OBTAINING AND USE | 2019 |
|
RU2803499C1 |
NOVEL HETEROCYCLIC DERIVATIVES AND THEIR PHARMACEUTICAL USING | 1996 |
|
RU2173316C2 |
NOVEL PYRROLE DERIVATIVE HAVING AS SUBSTITUTES UREIDE GROUP, AMINOCARBONYL GROUP AND BICYCLIC GROUP, OPTIONALLY SUBSTITUTED | 2009 |
|
RU2500669C2 |
ASYMMETRIC AUXILIARY GROUP | 2013 |
|
RU2693381C2 |
NITROGEN-CONTAINING HETEROCYCLIC AMIDE AND ITS USE FOR MEDICAL PURPOSES | 2019 |
|
RU2789670C2 |
DIHYDROPYRIMIDIN COMPOUNDS AND THEIR APPLICATION IN PHARMACEUTICALS | 2013 |
|
RU2655914C9 |
ARYLSULFONYLMETHYL OR ARYLSULFONAMIDE DERIVATIVES OF AROMATICS, PHARMACEUTICAL COMPOSITION BASED ON THEM AND WAY OF TREATMENT AGAINST ABNORMALITIES RESPONSIVE TO DOPAMINE D RECEPTOR LIGAND TREATMENT, WITH THEIR HELP | 2005 |
|
RU2442781C2 |
HETEROCYCLIC IMIDAZOLE COMPOUNDS, METHOD FOR THE PRODUCTION AND USE THEREOF | 2016 |
|
RU2686314C1 |
FIVE-MEMBERED HETEROCYCLIC PYRIDINE COMPOUNDS AND PREPARATION METHOD AND USE THEREOF | 2014 |
|
RU2668074C2 |
Authors
Dates
2020-05-25—Published
2015-12-28—Filed